Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Immunostimulation in heart surgery: thymostimulin. Preliminary data]

M Maccherini1, G Davoli, G Sani

  • 1Istituto di Chirurgia Toracica e Cardiovascolare, Ospedale Le Scotte, Università degli Studi di Siena.

Minerva Chirurgica
|December 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic kidney disease and valvular heart disease: State of the art.

Physiological reports·2025
Same author

Reference values of strain-derived myocardial work indices in heart transplant patients.

European heart journal. Imaging methods and practice·2024
Same author

Left ventricular assist device and transcatheter edge-to-edge mitral valve repair in advanced heart failure: allies or enemies?

Frontiers in cardiovascular medicine·2024
Same author

Heart transplantation and biomarkers: a review about their usefulness in clinical practice.

Frontiers in cardiovascular medicine·2024
Same author

A commentary on 'Focal vibration in dysphagia: A technological treatment for severe acquired brain injury rehabilitation'.

Journal of oral rehabilitation·2023
Same author

The burden of calcific aortic stenosis: what's behind?

European review for medical and pharmacological sciences·2023
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

This study investigated thymostimulin immunotherapy to counteract surgical immune depression in cardiac surgery patients. Thymostimulin treatment significantly improved immune response compared to controls, suggesting its potential for mitigating cardiopulmonary bypass-induced immune damage.

Area of Science:

  • Immunology
  • Cardiovascular Surgery
  • Pharmacology

Background:

  • Surgical procedures, particularly cardiac surgery involving cardiopulmonary bypass (CBP), induce significant immune depression.
  • Immunotherapy using thymic hormones has been explored to mitigate surgical immune deficits.
  • Cardiopulmonary bypass (CBP) is associated with profound immunosuppression.

Purpose of the Study:

  • To evaluate the efficacy of thymostimulin, an extractive thymic hormone, in preventing immune depression following cardiac surgery.
  • To assess the impact of thymostimulin on lymphocyte and T cell responses in patients undergoing CBP.

Main Methods:

  • A randomized controlled trial involving 40 cardiac surgery patients undergoing CBP.
  • Treatment group received thymostimulin (1 mg/kg/day), while the control group did not.

Related Experiment Videos

  • Immunological monitoring utilized the "multitest CMI" skin test to assess cellular immunity.

    • Main Results:

    • Patients treated with thymostimulin demonstrated a significant increase in immune response compared to the control group.
    • The "multitest CMI" indicated enhanced lymphocyte and T cell activity in the thymostimulin group.
    • Thymostimulin appears to counteract the immunosuppressive effects of cardiopulmonary bypass.

    Conclusions:

    • Thymostimulin immunotherapy shows promise in restoring immune function after cardiac surgery with cardiopulmonary bypass.
    • This study provides evidence for the beneficial immunomodulatory effects of thymostimulin in a surgical context.
    • Further research with larger cohorts and comprehensive immune assessments is warranted to confirm these findings.